Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Pieper

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 17, 2025
Emerging approaches to bridging discovery science with clinical care in Alzheimer's diseaseSubhash Sinha, Li Gan, Andrew A Pieper
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2025
Utilization of precision medicine digital twins for drug discovery in Alzheimer's diseaseYunxiao Ren, Andrew A Pieper, Feixiong Cheng
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 20, 2025
Erratum to 'Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease', Neurotherapeutics, 22(3), e00553Yunxiao Ren, Andrew A Pieper, Feixiong Cheng
Biomedicines|May 16, 2023
Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain InjurySarah Barker, Bindu D Paul, Andrew A Pieper
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 31, 2023
Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain InjuryPreethy S Sridharan, Emiko Miller, Andrew A Pieper
Experimental Neurology|May 18, 2017
Corrigendum to "The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after stroke" [Exp. Neurol. 290 (2017) 63-73]Zachary B Loris, Andrew A Pieper, W Dalton Dietrich
Drug Safety|July 15, 2011
Safety considerations in drug treatment of depression in HIV-positive patients: an updated reviewCrystal C Watkins, Andrew A Pieper, Glenn J Treisman
Experimental Neurology|January 13, 2017
The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic strokeZachary B Loris, Andrew A Pieper, W Dalton Dietrich
Chemical Society Reviews|February 12, 2014
P7C3 and an unbiased approach to drug discovery for neurodegenerative diseasesAndrew A Pieper, Steven L McKnight, Joseph M Ready
Neurogenesis (Austin, Tex.)|December 1, 2016
Cacna1c: Protecting young hippocampal neurons in the adult brainHéctor De Jesús-Cortés, Anjali M Rajadhyaksha, Andrew A Pieper
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 17, 2025
Emerging approaches to bridging discovery science with clinical care in Alzheimer's diseaseSubhash Sinha, Li Gan, Andrew A Pieper
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2025
Utilization of precision medicine digital twins for drug discovery in Alzheimer's diseaseYunxiao Ren, Andrew A Pieper, Feixiong Cheng
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 20, 2025
Erratum to 'Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease', Neurotherapeutics, 22(3), e00553Yunxiao Ren, Andrew A Pieper, Feixiong Cheng
Biomedicines|May 16, 2023
Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain InjurySarah Barker, Bindu D Paul, Andrew A Pieper
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 31, 2023
Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain InjuryPreethy S Sridharan, Emiko Miller, Andrew A Pieper
Experimental Neurology|May 18, 2017
Corrigendum to "The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after stroke" [Exp. Neurol. 290 (2017) 63-73]Zachary B Loris, Andrew A Pieper, W Dalton Dietrich
Drug Safety|July 15, 2011
Safety considerations in drug treatment of depression in HIV-positive patients: an updated reviewCrystal C Watkins, Andrew A Pieper, Glenn J Treisman
Experimental Neurology|January 13, 2017
The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic strokeZachary B Loris, Andrew A Pieper, W Dalton Dietrich
Chemical Society Reviews|February 12, 2014
P7C3 and an unbiased approach to drug discovery for neurodegenerative diseasesAndrew A Pieper, Steven L McKnight, Joseph M Ready
Neurogenesis (Austin, Tex.)|December 1, 2016
Cacna1c: Protecting young hippocampal neurons in the adult brainHéctor De Jesús-Cortés, Anjali M Rajadhyaksha, Andrew A Pieper
Pageof 15